18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Following Chimeric Antigen Receptor T-cell Therapy in Large B-cell Lymphoma.
Andrew RuffHatcher J BallardAustin R PantelEsin C NamogluMitchell E HughesSunita D NastaElise A ChongAdam BaggMarco RuellaMichael D FarwellJakub SvobodaMark A SellmyerPublished in: Molecular imaging and biology (2021)
Due to its excellent test characteristics and ability to detect asymptomatic disease, routine surveillance with PET/CT at 3 months after CART infusion is supported by our data. Earlier PET/CT may be of value in select situations as we did not find any cases of pseudoprogression.
Keyphrases
- pet ct
- positron emission tomography
- computed tomography
- public health
- pet imaging
- diffuse large b cell lymphoma
- electronic health record
- low dose
- clinical practice
- big data
- magnetic resonance imaging
- stem cells
- machine learning
- data analysis
- mesenchymal stem cells
- artificial intelligence
- deep learning
- smoking cessation